177 related articles for article (PubMed ID: 9608880)
1. Dose-dependent protection by azelastine eye drops against pollen-induced allergic conjunctivitis. A double-blind, placebo-controlled study.
Horak F; Berger UE; Menapace R; Toth J; Stübner PU; Marks B
Arzneimittelforschung; 1998 Apr; 48(4):379-84. PubMed ID: 9608880
[TBL] [Abstract][Full Text] [Related]
2. Azelastine eye drops reduce and prevent allergic conjunctival reaction and exert anti-allergic activity.
Ciprandi G; Buscaglia S; Catrullo A; Pesce G; Fiorino N; Montagna P; Bagnasco M; Canonica GW
Clin Exp Allergy; 1997 Feb; 27(2):182-91. PubMed ID: 9061218
[TBL] [Abstract][Full Text] [Related]
3. Comparison of azelastine eye drops with levocabastine eye drops in the treatment of seasonal allergic conjunctivitis.
Giede C; Metzenauer P; Petzold U; Ellers-Lenz B
Curr Med Res Opin; 2000; 16(3):153-63. PubMed ID: 11191004
[TBL] [Abstract][Full Text] [Related]
4. Time to onset and duration of action of the antihistamine bepotastine besilate ophthalmic solutions 1.0% and 1.5% in allergic conjunctivitis: a phase III, single-center, prospective, randomized, double-masked, placebo-controlled, conjunctival allergen challenge assessment in adults and children.
Abelson MB; Torkildsen GL; Williams JI; Gow JA; Gomes PJ; McNamara TR;
Clin Ther; 2009 Sep; 31(9):1908-21. PubMed ID: 19843481
[TBL] [Abstract][Full Text] [Related]
5. Rapid anti-inflammatory action of azelastine eyedrops for ongoing allergic reactions.
Ciprandi G; Cosentino C; Milanese M; Tosca MA
Ann Allergy Asthma Immunol; 2003 Apr; 90(4):434-8. PubMed ID: 12722967
[TBL] [Abstract][Full Text] [Related]
6. Azelastine eye drops in the treatment of perennial allergic conjunctivitis.
Nazarov O; Petzold U; Haase H; Nguyen DT; Ellers-Lenz B; Hermann R
Arzneimittelforschung; 2003; 53(3):167-73. PubMed ID: 12705171
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the onset and duration of effect of azelastine eye drops (0.05%) versus placebo in patients with allergic conjunctivitis using an allergen challenge model.
Friedlaender MH; Harris J; LaVallee N; Russell H; Shilstone J
Ophthalmology; 2000 Dec; 107(12):2152-7. PubMed ID: 11097587
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of intranasally applied dimethindene maleate solution as spray in adult volunteers with symptoms of seasonal allergic rhinitis in the Vienna challenge chamber.
Kyrein HJ; Horak F; Nirnberger G; Rehn D
Arzneimittelforschung; 1996 Aug; 46(8):794-9. PubMed ID: 9125281
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of single- and multiple-dose ketotifen fumarate 0.025% ophthalmic solution in a pediatric population.
Abelson MB; Ferzola NJ; McWhirter CL; Crampton HJ
Pediatr Allergy Immunol; 2004 Dec; 15(6):551-7. PubMed ID: 15610370
[TBL] [Abstract][Full Text] [Related]
10. Treatment of severe seasonal rhinoconjunctivitis by a combination of azelastine nasal spray and eye drops: a double-blind, double-placebo study.
Duarte C; Baëhre M; Gharakhanian S; Leynadier F;
J Investig Allergol Clin Immunol; 2001; 11(1):34-40. PubMed ID: 11436969
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the efficacy of olopatadine hydrochloride 0.1% ophthalmic solution and azelastine hydrochloride 0.05% ophthalmic solution in the conjunctival allergen challenge model.
Spangler DL; Bensch G; Berdy GJ
Clin Ther; 2001 Aug; 23(8):1272-80. PubMed ID: 11558863
[TBL] [Abstract][Full Text] [Related]
12. Azelastine eye-drops in seasonal allergic conjunctivitis or rhinoconjunctivitis. A double-blind, randomized, placebo-controlled study.
Giede-Tuch C; Westhoff M; Zarth A
Allergy; 1998 Sep; 53(9):857-62. PubMed ID: 9788686
[TBL] [Abstract][Full Text] [Related]
13. Azelastine eye drops reduce conjunctival hyperresponsiveness to hyperosmolar glucose challenge in children with asymptomatic mite conjunctivitis.
Ciprandi G; Catrullo A; Tosca M; Cerqueti P; Mondino C; Passalacqua G; Canonica GW
J Investig Allergol Clin Immunol; 1999; 9(1):35-8. PubMed ID: 10212855
[TBL] [Abstract][Full Text] [Related]
14. Prolonged effectiveness of bepotastine besilate ophthalmic solution for the treatment of ocular symptoms of allergic conjunctivitis.
Williams JI; Kennedy KS; Gow JA; Torkildsen GL; Abelson MB; Gomes PJ; McNamara TR;
J Ocul Pharmacol Ther; 2011 Aug; 27(4):385-93. PubMed ID: 21649522
[TBL] [Abstract][Full Text] [Related]
15. Double-blind, randomised, placebo-controlled study of two concentrations of azelastine eye drops in seasonal allergic conjunctivitis or rhinoconjunctivitis.
Lenhard G; Mivsek-Music E; Perrin-Fayolle M; Obtulowicz K; Secchi A
Curr Med Res Opin; 1997; 14(1):21-8. PubMed ID: 9524790
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and comfort of olopatadine 0.2% versus epinastine 0.05% ophthalmic solution for treating itching and redness induced by conjunctival allergen challenge.
Mah FS; Rosenwasser LJ; Townsend WD; Greiner JV; Bensch G
Curr Med Res Opin; 2007 Jun; 23(6):1445-52. PubMed ID: 17559743
[TBL] [Abstract][Full Text] [Related]
17. Effects of olopatadine hydrochloride nasal spray 0.6% in the treatment of seasonal allergic rhinitis: a phase III, multicenter, randomized, double-blind, active- and placebo-controlled study in adolescents and adults.
Shah SR; Nayak A; Ratner P; Roland P; Michael Wall G
Clin Ther; 2009 Jan; 31(1):99-107. PubMed ID: 19243710
[TBL] [Abstract][Full Text] [Related]
18. The effects of the nasal antihistamines olopatadine and azelastine in nasal allergen provocation.
Pipkorn P; Costantini C; Reynolds C; Wall M; Drake M; Sanico A; Proud D; Togias A
Ann Allergy Asthma Immunol; 2008 Jul; 101(1):82-9. PubMed ID: 18681089
[TBL] [Abstract][Full Text] [Related]
19. [Azelastine in the treatment of allergic conjunctivitis].
Vakhabova NT; Bakhritdinova FA
Vestn Oftalmol; 2001; 117(4):40-2. PubMed ID: 11569183
[TBL] [Abstract][Full Text] [Related]
20. Nasal ocular reflexes and eye symptoms in patients with allergic rhinitis.
Baroody FM; Foster KA; Markaryan A; deTineo M; Naclerio RM
Ann Allergy Asthma Immunol; 2008 Mar; 100(3):194-9. PubMed ID: 18426137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
